At the end of the latest market close, AC Immune SA (ACIU) was valued at $5.78. In that particular session, Stock kicked-off at the price of $5.71 while reaching the peak value of $7.20 and lowest value recorded on the day was $5.67. The stock current value is $6.41.
Recently in News on December 15, 2020, AC Immune Receives Competitive Target ALS Foundation Grant to Accelerate the Development of Proprietary Phosphorylated TDP-43 Immuno-assay. Grant provides USD 600,000 in funding to support a world-class collaboration between AC Immune and Massachusetts General Hospital. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
AC Immune SA had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.20 on 01/11/21, with the lowest value was $4.99 for the same time period, recorded on 01/04/21.
AC Immune SA (ACIU) full year performance was -31.08%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AC Immune SA shares are logging -50.69% during the 52-week period from high price, and 57.49% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.07 and $13.00.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1194335 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the AC Immune SA (ACIU) recorded performance in the market was 23.98%, having the revenues showcasing 24.95% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 451.90M, as it employees total of 115 workers.
Market experts do have their say about AC Immune SA (ACIU)
During the last month, 3 analysts gave the AC Immune SA a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.81, with a change in the price was noted -0.59. In a similar fashion, AC Immune SA posted a movement of -8.43% for the period of last 100 days, recording 377,512 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ACIU is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.
Technical breakdown of AC Immune SA (ACIU)
Raw Stochastic average of AC Immune SA in the period of last 50 days is set at 71.58%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 66.09%. In the last 20 days, the company’s Stochastic %K was 84.55% and its Stochastic %D was recorded 89.89%.
Bearing in mind the latest performance of AC Immune SA, several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 23.98%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -6.56%, alongside a downfall of -31.08% for the period of the last 12 months. The shares increased approximately by 20.49% in the 7-day charts and went down by 30.55% in the period of the last 30 days. Common stock shares were driven by 24.95% during last recorded quarter.